Ownership Summary
A total of 4 institutions have reported a stake in ProMIS Neurosciences Inc. (NASDAQ:PMN) as of December 2025, according to recent 13F filings with the SEC.
- These investors collectively held 0.1% of the company's total shares outstanding in December 2025, down from 514.3% in September 2025.
- On a quarter-over-quarter basis, institutional holdings shifted by nan%, with a year-over-year a decrease of 78.95% in the count of filers.
- A review of institutional activity for ProMIS Neurosciences shows 4 of 4 filers increasing their positions, while 0 reduced their stake, and 0 remained unchanged.
- Collectively, institutional investors increased their stake in ProMIS Neurosciences to 2.81K shares as of December 2025, a change that is up by 2.81K shares quarter on quarter and down 9.74Mn shares year over year.
- With 1.45K shares, UBS Group AG commands the largest institutional position in ProMIS Neurosciences as of December 31, 2025, equating to 0.08% of the company.
- Among the most significant buyers of ProMIS Neurosciences during December 2025 were UBS Group AG (1.45K), Disciplined Equity Management, Inc. (1.00K), Federation des caisses Desjardins du Quebec (330), TD Waterhouse Canada Inc. (25).
- The top 4 institutional holders of ProMIS Neurosciences for the quarter ending December 2025 included UBS Group AG (1.45K), Disciplined Equity Management, Inc. (1.00K), Federation des caisses Desjardins du Quebec (330), TD Waterhouse Canada Inc. (25).